🌚 Solar Stocks Go Dark

+ This Stock Has Rallied 59,000% This Year

In partnership with

Good afternoon! Novo Nordisk just made a billion-dollar blunder over a $450 fee. The Danish pharma giant behind Ozempic and Wegovy let its Canadian patent on semaglutide lapse after failing to pay a routine maintenance fee. Canada, the second-largest market for the drug, will now see generics hit shelves as soon as 2026. For a company pulling in billions, this slip-up is shaping up to be one of the most expensive clerical errors in pharmaceutical history.

The mistake comes as Novo faces mounting challenges. It's already struggling to keep up with demand, losing ground to Eli Lilly and smaller players producing compounded alternatives. Its next-generation drug pipeline hasn't impressed, and after a 50 percent drop in stock and the CEO’s recent resignation, that missed payment looks less like an oversight and more like a symptom of deeper issues.

MARKETS

*Stock data as of market close*

  • Markets lost steam Tuesday as fresh tension in the Middle East rattled investors. President Trump’s demand for Iran’s ā€œunconditional surrenderā€ and evacuation warnings for Americans in Tehran sent oil higher and stocks lower, with the S&P 500 falling 0.8%.

  • Consumer and healthcare sectors were hit hardest, the latter dragged by reports of a possible pharma ad crackdown. A peaceful resolution looked less likely and Wall Street took notice.

STOCKS
Winners & Losers

What’s up šŸ“ˆ

  • Verve Therapeutics exploded 81.50% on news that the gene-editing company will be acquired by Eli Lilly in a $1.3 billion deal. ($VERV)

  • BGSF surged 33.58% after the staffing company announced it is selling its professional division to INSPYR Solutions for $99 million. ($BGSF)

  • Reddit popped 6.05% after the social media site rolled out new AI-powered tools for advertisers. ($RDDT)

  • Jabil gained 8.89% thanks to a strong earnings report for the electronics parts supplier. ($JBL)

  • Oil stocks climbed as the conflict between Israel and Iran threatens to grow: Valero Energy rose 2.91% ($VLO), Chevron gained 1.93% ($CVX), and Hess added 1.81% ($HES).

What’s down šŸ“‰

  • JetBlue Airways lost 7.88% after announcing cost cuts due to weaker travel demand. ($JBLU)

  • United Airlines dropped 6.18% and Delta Air Lines fell 4.33% as oil prices rose and travel concerns mounted. ($UAL, $DAL)

  • T-Mobile tumbled 4.14% after SoftBank sold 21.5 million shares in a large overnight offering. ($TMUS)

  • Lennar sank 4.46% after missing profit forecasts despite beating revenue expectations. ($LEN)

  • Microsoft slipped 0.23% following reports that its partnership with OpenAI is under stress. ($MSFT)

SOLAR
Senate Wants to End Wind, Solar Tax Credits

Senate Republicans just dropped their version of President Trump’s sweeping tax bill, and residential solar didn’t make the cut. The new proposal would scrap tax credits that once shaved thousands off the cost of rooftop solar, potentially expiring them just 180 days after passage.

That’s no small hit. Without credits, a $20,000 solar install becomes, well, a $20,000 install. For Sunrun, Enphase, and SolarEdge whose business models are tightly intertwined with those subsidies—it’s a nightmare scenario. Their stocks cratered on Tuesday, with Sunrun plunging 40% and its peers not far behind.

Winners, Losers, and the Not-So-Green Middle

Not all clean energy got burned. The Senate bill threw a bone to nuclear, geothermal, biofuels, and battery storage. Constellation Energy ticked higher, riding renewed support for nuclear. Fluence Energy surged 13% on battery optimism. Even utilities in solar-heavy states like California might get some relief from storage incentives.

Still, solar and wind will see their incentives fade starting in 2026, disappearing entirely by 2028. That’s only slightly better than the House version—and not the solar sector lifeline investors had hoped for.

Dimmed Hopes, Not Dead Dreams

There might be a loophole, though. Companies that sell electricity via power purchase agreements, instead of direct installs, could still qualify for some credits. Sunrun uses this model often, giving the industry a glimmer of hope if the language survives into the final bill.

Bottom line: Rooftop solar isn't dead, but it's definitely feeling under the weather. Investors hoping for a Senate rescue are learning that sometimes the (sun)light at the end of the tunnel is just a tax code change.

NEWS
Market Movements

STOCK
Regencell’s mind-bending 59,000% rally turns a mystery stock into a $30 billion giant

You’ve probably never heard of Regencell Bioscience and you’re not alone. The Hong Kong-based herbal medicine company makes no money, has no product on the market, and was trading like a penny stock just a few months ago. Now? It’s worth more than Dropbox and Wayfair combined.

Shares of Regencell ($RGC) exploded after a 38-for-1 stock split last week, soaring 283% in a single day and more than 59,000% this year. The stock has become so volatile it triggered over 10 halts Monday alone. But unlike most meme rallies, this one isn’t backed by Reddit hype or any earnings, for that matter.

A Rally Built on Vapor

Here’s the setup: Regencell has a tiny float (just 6% of shares are publicly available), and nearly all the rest is owned by insiders, including its CEO Yat-Gai Au whose stake is now worth over $30 billion. With so few shares out there and short interest topping 94%, the ingredients are there for a monster squeeze. That’s exactly what seems to be happening.

The company itself? Still in R&D, working on traditional Chinese medicine formulas for ADHD and autism. It has no regulatory approvals, no distribution capacity, and hasn’t sold a single product. But that hasn’t stopped it from raising money, including $21 million from its 2021 IPO and additional rounds since. It even briefly flirted with Covid treatments in 2022.

From Penny Stock to Billionaire Factory

Regencell’s rise has turned heads and made its execs rich. But with its chief medical officer role vacant since 2022 and zero proven therapies on the market, the surge is raising serious eyebrows across Wall Street. Even the company’s founder admits it's his ā€œpassion project,ā€ not a polished pharma play.

Bottom line: Regencell might be the clearest example of how financial alchemy, low float, and a well-timed stock split can conjure billions in value without a dollar of revenue in sight. Blink, and the next halt might just be reality catching up.

Calendar
On The Horizon

Tomorrow

Wednesday’s earnings calendar is a snoozefest, but housing data will give markets something to chew on. The latest report on housing starts will show how many new homes broke ground last month, offering clues about whether builders are finally addressing the chronic supply crunch frustrating buyers.

But the main event hits in the afternoon, when the Fed wraps up its latest policy meeting. All eyes will be on Jerome Powell, who’s widely expected to keep rates steady—Wall Street is pricing in a 99% chance of no change. No surprises, just vibes.

Final Chance to Own a Piece of Virtuix

Virtuix is redefining the future of immersive entertainment — and time is running out to join in. Its flagship ā€œOmniā€ treadmill lets users physically walk and run in 360 degrees through virtual worlds, with real-world applications across gaming, fitness, and military training.

āœ… $18M+ in product sales
āœ… 400K+ registered players
āœ… 4X revenue growth in the last fiscal year
āœ… Backed by $40M+ from top investors, including Shark Tank’s Kevin O’Leary

With over $2.7M raised in this round, investor demand is accelerating — but the raise closes June 20.

This is your final chance to back one of the most exciting players in the VR space.

This Reg CF offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

NEWS
The Daily Rundown

REFERRAL
Share Investinq šŸ¤ Acquire Swag

If you love reading our newsletter, don’t be selfish — share it. Odds are your favorite finance bro, trader, investor, or stock market fanatic will too.

Don’t keep all the market news to yourself — share the love using the unique link below.

We deliver you all the news for free every single day (go on… help us out ;)

And here’s the kicker: every referral you make gets you entered into a raffle to win some awesome prizes listed below. Just share the link below and you’ll be entered once they sign up.

RESOURCES
The Federal Reserve Resource

Join our small yet growing subreddit šŸš€: https://www.reddit.com/r/investinq/

Wall Street Reads šŸ’Ž (Best Books):

Check out our latest issues šŸŽÆ: https://investinq.beehiiv.com